Thank you, David, and welcome, everyone, to Innospec fourth quarter and full year 2024 conference call. This was another good quarter for Innospec as we exceeded earnings expectations despite the reduced Oilfield Services activity in Latin America. In Performance Chemicals, we delivered double-digit operating income growth over the fourth quarter last year driven by improved sales and margins. We have a balanced pipeline of growth opportunities across our global personal care, home care, agriculture, construction, and other industrial markets. In addition, the integration and performance of our recent QGP acquisition in Brazil is proceeding to plan and is supporting not only Performance Chemicals but also Fuel Specialties growth opportunities in the region. Moving to 2025, we continue to target operating income and margin improvement to levels consistent with full year 2022. In Fuel Specialties, operating income increased 7% over the same quarter last year, and operating margin improved to just below our target of 19% to 21%. We remain focused on further margin improvement in parallel with top-line growth. With our industry-leading innovation and customer service capabilities, we are well-positioned to continue advancing our global customers' initiatives. Our technology will continue to focus on cleaner fuels, lowering emissions, and improving efficiency in traditional, renewable, and non-fuel applications. In Oilfield Services, as expected, results were similar to the third quarter of no recover in Latin America production chemical activity. We currently do not expect this activity to resume in the near term. In 2025, we remain focused on continuing to drive sequential quarterly improvements in our core businesses, including U.S. completions and production, DRA in the Middle East. Now I will turn the call to Ian Cleminson, who will review our financial results in more detail. Then I will return with some concluding comments. After that, Ian, I will take your questions. Ian?